Legal Representation
Attorney
Kevin G. Smith
USPTO Deadlines
Next Deadline
1631 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-12-26)
Due Date
December 26, 2029
Grace Period Ends
June 26, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
18 events| Date | Code | Type | Description |
|---|---|---|---|
| Dec 26, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Dec 26, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Oct 10, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Oct 10, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Sep 20, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Sep 7, 2023 | FIXD | O | ELECTRONIC RECORD REVIEW COMPLETE |
| Sep 1, 2023 | ERRR | O | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Aug 29, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Aug 15, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Aug 15, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Aug 15, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| May 16, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN |
| May 16, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED |
| May 16, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| May 10, 2023 | DOCK | D | ASSIGNED TO EXAMINER |
| Aug 17, 2022 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Aug 16, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jul 28, 2022 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops for treating a wide range of medical conditions
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Pharmaceutical drug development services
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of the Greek letter "Phi" centered above four Arabic characters which are above the wording "PHARMA INTERNATIONAL" and below are four diverging shaded lines underneath.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
PHI PHARMA INTERNATIONAL
Other
The non-Latin characters in the mark transliterate to AL DAWLEAH LAL DAWA and this means PHARMA INTERNATIONAL in English.
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMA INTERNATIONAL" OR THE NON-LATIN CHARACTERS THAT TRANSLITERATE TO "PHARMA INTERNATIONAL"